GlassScriptPhysician profile
Dirk A Bakker
NPI 1881692077
$5,764.39
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,633 · 2020: $84.69 · 2021: $256 · 2022: $230 · 2023: $228 · 2024: $182 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,673.98 | 2019 | |
| Medwest Associates | $606.80 | 2019-2022 | |
| Pacira Therapeutics, INC. | $282.67 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $259.45 | 2023-2025 | Tapestry, Rosa, Gel-One Cross-Linked Hyaluronate |
| Stryker Corporation | $251.97 | 2019-2023 | Mako |
| Heron Therapeutics, INC. | $208.00 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $78.45 | 2025 | |
| Avanos Medical | $70.31 | 2019 | |
| Radius Health, INC. | $65.68 | 2019-2023 | Tymlos |
| Orthofix Medical, INC. | $62.76 | 2019 | |
| Intersect Ent, INC. | $33.33 | 2019 | |
| Catalyst Orthoscience | $31.60 | 2019 | |
| Abbott Laboratories | $29.50 | 2025 | Proclaim |
| Anika Therapeutics, INC. | $28.15 | 2021 | |
| Ferring Pharmaceuticals INC. | $25.83 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $17.92 | 2024 | Nalu Neurostimulation System |
| Embody, INC. | $14.94 | 2023 | |
| Bioventus LLC | $12.02 | 2020 | |
| Mallinckrodt Enterprises LLC | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$315,281.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dirk Bakker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.